360 related articles for article (PubMed ID: 12182539)
1. A reduced immunization scheme to obtain an experimental anti-Loxosceles laeta ("violinist spider") venom.
de Roodt AR; Litwin S; Dokmetjian JC; Vidal JC
J Nat Toxins; 2002 Aug; 11(3):193-203. PubMed ID: 12182539
[TBL] [Abstract][Full Text] [Related]
2. Toxicity of two North American Loxosceles (brown recluse spiders) venoms and their neutralization by antivenoms.
de Roodt AR; Estevez-Ramírez J; Litwin S; Magaña P; Olvera A; Alagón A
Clin Toxicol (Phila); 2007 Sep; 45(6):678-87. PubMed ID: 17849243
[TBL] [Abstract][Full Text] [Related]
3. Innovative immunization protocols using chimeric recombinant protein for the production of polyspecific loxoscelic antivenom in horses.
Figueiredo LF; Dias-Lopes C; Alvarenga LM; Mendes TM; Machado-de-Ávila RA; McCormack J; Minozzo JC; Kalapothakis E; Chávez-Olórtegui C
Toxicon; 2014 Aug; 86():59-67. PubMed ID: 24878371
[TBL] [Abstract][Full Text] [Related]
4. North and South American Loxosceles spiders: development of a polyvalent antivenom with recombinant sphingomyelinases D as antigens.
Olvera A; Ramos-Cerrillo B; Estévez J; Clement H; de Roodt A; Paniagua-Solís J; Vázquez H; Zavaleta A; Arruz MS; Stock RP; Alagón A
Toxicon; 2006 Jul; 48(1):64-74. PubMed ID: 16759681
[TBL] [Abstract][Full Text] [Related]
5. A new anti-loxoscelic serum produced against recombinant sphingomyelinase D: results of preclinical trials.
de Almeida DM; Fernandes-Pedrosa Mde F; de Andrade RM; Marcelino JR; Gondo-Higashi H; de Azevedo Ide L; Ho PL; van den Berg C; Tambourgi DV
Am J Trop Med Hyg; 2008 Sep; 79(3):463-70. PubMed ID: 18784245
[TBL] [Abstract][Full Text] [Related]
6. Synthetic peptides for in vitro evaluation of the neutralizing potency of Loxosceles antivenoms.
Ramada JS; Becker-Finco A; Minozzo JC; Felicori LF; Machado de Avila RA; Molina F; Nguyen C; de Moura J; Chávez-Olórtegui C; Alvarenga LM
Toxicon; 2013 Oct; 73():47-55. PubMed ID: 23856101
[TBL] [Abstract][Full Text] [Related]
7. Biochemical and immunological characteristics of Peruvian Loxosceles laeta spider venom: neutralization of its toxic effects by anti-loxoscelic antivenoms.
Guimarães G; Dias-Lopes C; Duarte CG; Felicori L; Machado de Avila RA; Figueiredo LF; de Moura J; Faleiro BT; Barro J; Flores K; Silva W; Tintaya B; Yarleque A; Bonilla C; Kalapothakis E; Salas CE; Chávez-Olortegui C
Toxicon; 2013 Aug; 70():90-7. PubMed ID: 23648420
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous loxoscelism caused by Loxosceles similis venom and neutralization capacity of its specific antivenom.
Chatzaki M; Horta CC; Almeida MO; Pereira NB; Mendes TM; Dias-Lopes C; Guimarães G; Moro L; Chávez-Olórtegui C; Horta MC; Kalapothakis E
Toxicon; 2012 Jul; 60(1):21-30. PubMed ID: 22465492
[TBL] [Abstract][Full Text] [Related]
9. Enzymatic characterization, antigenic cross-reactivity and neutralization of dermonecrotic activity of five Loxosceles spider venoms of medical importance in the Americas.
Barbaro KC; Knysak I; Martins R; Hogan C; Winkel K
Toxicon; 2005 Mar; 45(4):489-99. PubMed ID: 15733571
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of antivenom in loxoscelism treatment.
Pauli I; Puka J; Gubert IC; Minozzo JC
Toxicon; 2006 Aug; 48(2):123-37. PubMed ID: 16808942
[TBL] [Abstract][Full Text] [Related]
11. Analysis of therapeutic benefits of antivenin at different time intervals after experimental envenomation in rabbits by venom of the brown spider (Loxosceles intermedia).
Pauli I; Minozzo JC; da Silva PH; Chaim OM; Veiga SS
Toxicon; 2009 May; 53(6):660-71. PubMed ID: 19673081
[TBL] [Abstract][Full Text] [Related]
12. Anti-loxoscelic horse serum produced against a recombinant dermonecrotic protein of Brazilian Loxosceles intermedia spider neutralize lethal effects of Loxosceles laeta venom from Peru.
Duarte CG; Bonilla C; Guimarães G; Machado de Avila RA; Mendes TM; Silva W; Tintaya B; Yarleque A; Chávez-Olórtegui C
Toxicon; 2015 Jan; 93():37-40. PubMed ID: 25448393
[TBL] [Abstract][Full Text] [Related]
13. Variations in Loxosceles spider venom composition and toxicity contribute to the severity of envenomation.
de Oliveira KC; Gonçalves de Andrade RM; Piazza RM; Ferreira JM; van den Berg CW; Tambourgi DV
Toxicon; 2005 Mar; 45(4):421-9. PubMed ID: 15733563
[TBL] [Abstract][Full Text] [Related]
14. Recombinant Protein Containing B-Cell Epitopes of Different
Lima SA; Guerra-Duarte C; Costal-Oliveira F; Mendes TM; Figueiredo LFM; Oliveira D; Machado de Avila RA; Ferrer VP; Trevisan-Silva D; Veiga SS; Minozzo JC; Kalapothakis E; Chávez-Olórtegui C
Front Immunol; 2018; 9():653. PubMed ID: 29666624
[TBL] [Abstract][Full Text] [Related]
15. Tetracycline and penicillin resistant Clostridium perfringens isolated from the fangs and venom glands of Loxosceles laeta: its implications in loxoscelism treatment.
Catalán A; Espoz MC; Cortés W; Sagua H; González J; Araya JE
Toxicon; 2010 Nov; 56(6):890-6. PubMed ID: 20600224
[TBL] [Abstract][Full Text] [Related]
16. Functional characterization and epitope analysis of a recombinant dermonecrotic protein from Loxosceles intermedia spider.
Felicori L; Araujo SC; de Avila RA; Sanchez EF; Granier C; Kalapothakis E; Chávez-Olórtegui C
Toxicon; 2006 Oct; 48(5):509-19. PubMed ID: 16934304
[TBL] [Abstract][Full Text] [Related]
17. Role of IgG(T) and IgGa isotypes obtained from arachnidic antivenom to neutralize toxic activities of Loxosceles gaucho, Phoneutria nigriventer and Tityus serrulatus venoms.
Toro AF; Malta MB; Soares SL; Da Rocha GC; da Silva Lira M; De Oliveira TA; Takehara HA; Lopes-Ferreira M; Santoro ML; Guidolin R; Gondo Higashi H; Fernandes I; Barbaro KC
Toxicon; 2006 Nov; 48(6):649-61. PubMed ID: 16979205
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the venom from the Brazilian Brown Spider Loxosceles similis Moenkhaus, 1898 (Araneae, Sicariidae).
Silvestre FG; de Castro CS; de Moura JF; Giusta MS; De Maria M; Alvares ES; Lobato FC; Assis RA; Gonçalves LA; Gubert IC; Chávez-Olórtegui C; Kalapothakis E
Toxicon; 2005 Dec; 46(8):927-36. PubMed ID: 16289643
[TBL] [Abstract][Full Text] [Related]
19. An in vivo protective response against toxic effects of the dermonecrotic protein from Loxosceles intermedia spider venom elicited by synthetic epitopes.
Felicori L; Fernandes PB; Giusta MS; Duarte CG; Kalapothakis E; Nguyen C; Molina F; Granier C; Chávez-Olórtegui C
Vaccine; 2009 Jun; 27(31):4201-8. PubMed ID: 19389441
[TBL] [Abstract][Full Text] [Related]
20. Protection against dermonecrotic and lethal activities of Loxosceles intermedia spider venom by immunization with a fused recombinant protein.
Araujo SC; Castanheira P; Alvarenga LM; Mangili OC; Kalapothakis E; Chávez-Olórtegui C
Toxicon; 2003 Mar; 41(3):261-7. PubMed ID: 12565747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
